Target Gene/Pathway Pathway / Gene
Search results
| No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | 指定難病告示番号 |
|---|---|---|---|---|---|
| 1 | B cell receptor signaling pathway 💬 19 genes, 29 drugs (DrugBank) and 68 diseases |
CD19 1件: CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 4件: 11, 13, 51, 300 💬
|
| 2 | B cell receptor signaling pathway 💬 19 genes, 29 drugs (DrugBank) and 68 diseases |
CD19 1件: CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 300 1件: 300 💬
|
| 3 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
CD19 1件: CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 4件: 11, 13, 51, 300 💬
|
| 4 | Epstein-Barr virus infection 💬 44 genes, 62 drugs (DrugBank) and 66 diseases |
CD19 1件: CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 300 1件: 300 💬
|
| 5 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
CD19 1件: CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 4件: 11, 13, 51, 300 💬
|
| 6 | Hematopoietic cell lineage 💬 32 genes, 70 drugs (DrugBank) and 90 diseases |
CD19 1件: CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 300 1件: 300 💬
|
| 7 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
CD19 1件: CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 4件: 11, 13, 51, 300 💬
|
| 8 | PI3K-Akt signaling pathway 💬 76 genes, 112 drugs (DrugBank) and 112 diseases |
CD19 1件: CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 300 1件: 300 💬
|
| 9 | Primary immunodeficiency 💬 11 genes, 23 drugs (DrugBank) and 26 diseases |
CD19 1件: CD19 💬
|
Inebilizumab Inebilizumab 💬
| Inebilizumab | 011 4件: 11, 13, 51, 300 💬
|
| 10 | Primary immunodeficiency 💬 11 genes, 23 drugs (DrugBank) and 26 diseases |
CD19 1件: CD19 💬
|
Obexelimab Obexelimab 💬
| Obexelimab | 300 1件: 300 💬
|